Replimune Group Inc.

Replimune is a biotechnology company based in Woburn, Massachusetts that is pioneering the development of novel tumor-directed oncolytic immunotherapies. Their mission is to revolutionize cancer treatment by activating a powerful and durable full-body anti-tumor immune response. Replimune has multiple ongoing clinical trials evaluating the safety and effectiveness of their investigational therapies in a range of solid tumor cancers.